Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human P2Y12 ELISA Kit (AC3761)
Cat.#: ASET-2350
Specifications
Description Human P2Y12 ELISA Kit allows for the in vitro quantitative determination of human P2Y12 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1309 Human Plasminogen Activator ELISA Kit (AC2720) Quantitative inquiry ASET-1026 Human Cadherin 8 ELISA Kit (AC2437) Quantitative inquiry ASET-1802 Human TMEM158 ELISA Kit (AC3213) Quantitative inquiry ASET-2234 Human Cx30 ELISA Kit (AC3645) Quantitative inquiry ASET-2210 Monkey TIMP1 ELISA Kit (AC3621) Quantitative inquiry ASET-2229 Mouse GABA ELISA Kit (AC3640) Quantitative inquiry ASET-1408 Horse Luteinizing Hormone ELISA Kit (AC2819) Quantitative inquiry ASET-1164 Human SATB2 ELISA Kit (AC2575) Quantitative inquiry ASET-1883 Human 5HT1B Receptor ELISA Kit (AC3294) Quantitative inquiry ASET-1673 Mouse NKCC1 ELISA Kit (AC3084) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket